Announcements Trials
Browse Landscape

Phase

Phase 2 36Phase 3 19Phase 1/2 14Phase 1 14Phase 4 6Phase NA 2Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 19Other hematologic neoplasm 17Myeloid 8Plasma cell 7Dermatologic 6Sarcoma 5Classical hematology 3CNS 2Breast 2Other solid neoplasm 1Head & Neck 1Genitourinary 1

Conditions

Breast Neoplasms 2Inflammatory Breast Neoplasms 1

Interventions

Exercise 126Surveys and Questionnaires 59Standard of Care 58Early Intervention, Educational 55Methods 54Educational Status 53Magnetic Resonance Spectroscopy 50Acupuncture Therapy 48Blood Specimen Collection 46Radiotherapy 39Mammography 39Control Groups 35Counseling 32Therapeutics 30Practice Guidelines as Topic 30Cyclophosphamide 29Biopsy 28Sentinel Lymph Node Biopsy 27Psychiatric Rehabilitation 27Yoga 23Neoadjuvant Therapy 23Mastectomy, Segmental 23Resistance Training 22Interviews as Topic 21Surgical Procedures, Operative 19Palliative Care 19High-Energy Shock Waves 19Trastuzumab 18Doxorubicin 18Cognitive Behavioral Therapy 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Filgrastim × Breast × Clear all
NCT05296317 2026-02-19

EMEG-ECDD

Centre Georges Francois Leclerc

Phase NA Completed
97 enrolled
Breast

Breast Neoplasms

NCT00310089 2013-06-20

AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer

National Cancer Institute (NCI)

Phase NA Completed
33 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡